Trials / Recruiting
RecruitingNCT05503290
The Lullaby Project as a Musical Intervention for Pregnant Individuals With Epilepsy
A Pilot Study for the Lullaby Project as a Musical Intervention for Pregnant Individuals With Epilepsy
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- University Health Network, Toronto · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study's proposed intervention is the randomized participation of pregnant individuals with epilepsy in the Lullaby Project coordinated by a musical institution in Toronto. The purpose of this present study is to investigate the potential benefits of the Lullaby Project on pregnant individuals with epilepsy. Namely, effects on quality of life-related to epilepsy, symptoms of depression and anxiety, perceived stress, and feelings of empowerment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Lullaby Project | Our proposed intervention is the randomized participation of pregnant individuals with epilepsy in the Lullaby Project coordinated by a musical institution in Toronto. The Lullaby Project is an initiative first created by Carnegie Hall's Weill Music Institute. In this program, pregnant women and/or new mothers are paired with professional musicians to compose and write personal lullabies for their child(ren). Since its inception in 2011, the project has expanded globally and have helped numerous families write original lullabies for their newborns. The Lullaby intervention is unlike traditional music therapy as patients are actively participating in the creative song-writing process, not singularly in passive listening. Through sessions, participants will be given an opportunity to share experiences, experiment with musical arrangements, write lyrics, and receive positive feedback from the musician. |
Timeline
- Start date
- 2023-01-23
- Primary completion
- 2025-01-01
- Completion
- 2025-01-01
- First posted
- 2022-08-16
- Last updated
- 2024-06-03
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05503290. Inclusion in this directory is not an endorsement.